XLRN
Acceleron Pharma
XLRN
XLRN
Delisted
XLRN was delisted on the 19th of November, 2021.
166 hedge funds and large institutions have $1.97B invested in Acceleron Pharma in 2019 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 61 increasing their positions, 46 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
12% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 25
14% less capital invested
Capital invested by funds: $2.3B → $1.97B (-$323M)
Holders
166
Holding in Top 10
4
Calls
$5.8M
Puts
$6.14M
Top Buyers
| 1 | +$15.2M | |
| 2 | +$11.4M | |
| 3 | +$9.9M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$7.98M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$7.25M |
Top Sellers
| 1 | -$37.7M | |
| 2 | -$29.6M | |
| 3 | -$13.3M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$12.5M |
| 5 |
State Street
Boston,
Massachusetts
|
-$12.1M |